key: cord-0268516-ta4mxm8h
authors: Hosch, Salome; Yoboue, Charlene Aya; Donfack, Olivier Tresor; Guirou, Etienne A.; Dangy, Jean-Pierre; Mpina, Maxmillian; Nyakurungu, Elizabeth; Blöchliger, Koranan; Guerra, Carlos A.; Phiri, Wonder P.; Ayekaba, Mitoha Ondo’o; García, Guillermo A.; Tanner, Marcel; Daubenberger, Claudia; Schindler, Tobias
title: Analysis of nucleic acids extracted from rapid diagnostic tests reveals a significant proportion of false positive test results associated with recent malaria treatment
date: 2021-05-13
journal: bioRxiv
DOI: 10.1101/2021.05.12.443950
sha: 1f0280c5bcc6746e47ac1c222aaa81091d18c3b3
doc_id: 268516
cord_uid: ta4mxm8h

Surveillance programs often use malaria rapid diagnostic tests (RDTs) to determine the proportion of the population carrying parasites in their peripheral blood to assess the malaria transmission intensity. Despite an increasing number of reports on false-negative and false-positive RDT results, there is a lack of systematic quality control activities for RDTs deployed in malaria surveillance programs. Our study provides a larger scale comparative evaluation of RDTs used in the 2018 Malaria Indicator Survey (MIS) conducted on Bioko Island, Equatorial Guinea. We conducted a molecular analysis by extraction of nucleic acids from 1,800 negative and 1,065 positive RDTs followed by qPCR analysis. These results were combined with a dataset collected in a comprehensive questionnaire from each MIS participant. Of the 2,865 RDTs that were collected in 2018 on Bioko Island and analysed in our study, 4.7% had a false-negative result. These false-negative RDT results were associated with low parasite density infections. In a substantial proportion of samples, we identified masked pfhrp2 and pfhrp3 gene deletions in which at least one P. falciparum strain carried a gene deletion. Among all positive RDTs analysed, 28.4% were tested negative by qPCR and therefore considered to be false-positive. Analysing the questionnaire data collected from the participants, this high proportion of false-positive RDT results could be explained by PfHRP2 antigen persistence after recent malaria treatment. We conclude that malaria surveillance depending solely on RDTs needs well-integrated quality control procedures assessing the extend and impact of reduced sensitivity and specificity of RDTs on malaria control programs.

According to the World Health Organization, more than 409,000 malaria deaths were reported 57 in 2019, most of them in children below the age of five years 1 . The majority of malaria 58 infections (94%) and malaria related deaths (95%) occurred in sub-Saharan Africa (sSA), where 59

Plasmodium falciparum (Pf) is the dominant malaria parasite 1 . The test-treat-track strategy 60 advised by WHO is one of the backbones of current malaria control and elimination programs 61 9 sample. We ran the qHRP2/3-del assay only with NA extracted from RDTs that had displayed 167 a Cq < 35 for the varATS target in the PlasQ Pfrnr2e2, pfhrp2, and pfhrp3 are all single-copy genes and they show comparable performances 169 in the multiplex qPCR assay 30 . One approach to detect Pf strains with pfhrp2 and/or pfhrp3 170 gene deletions in mixed Pf strain infections (herein defined as masked gene deletions) is to 171 calculate the difference in Cq values obtained between pfhrp2 or pfhrp3 and pfrnr2e2 172 amplifications (ΔCq values). This is done by subtracting the Cq value obtained during the 173 amplification of pfrnr2e2 from the Cq value of pfhrp2 or pfhrp3, respectively. Combining all 174 runs that were conducted, the mean ΔCq for pfhrp2 in controls (NF54 and HB3) was 0.00 (SD 175 ±0.52) and for pfhrp3 the mean ΔCq in controls (NF54 and Dd2) was 1.19 (SD ±0.83). For 176 pfhrp2 a ΔCq cut-off value of 1.0 (mean + 2x SD for controls) was chosen to identify masked 177 gene deletions. For pfhrp3 a ΔCq cut-off value of 2.9 (mean + 2x SD for controls) was chosen 178 to identify masked gene deletions. 179

Genotyping with pfmsp1 and pfmsp2 was performed following published procedures using 181 nested PCR 31 . The first two PCR reactions amplify conserved sequences within the 182 polymorphic regions of pfmsp1 and pfmsp2, respectively. The second, nested PCR targets 183 allele-specific sequences in five separate reactions. Samples were run in 20 µL total volume 184 was used for calculation of odds ratios and their confidence intervals. 217

All data needed to evaluate the conclusions in the paper are present in the manuscript or the 219 Supplementary Materials. Further information will be made available to interested researchers. 220

The 15 sequences of P. malariae circumsporozoite protein from Bioko Island have been 221 When stratified by the type of antigen, FP-RDTs were predominantly those that detected only 242 the PfHRP2 antigen (88.4%) during the MIS; whereas 8.9% and 2.6% of the FP-RDTs were 243 respectively those that detected both, the PfHRP2 plus the pLDH antigens, and those that 244 detected the pLDH antigen only. Around half of TP-RDTs were those that detected the PfHRP2 245 antigen only (50.1%), followed by those that detected both antigens (45.9%) and lastly, those 246 that detected the pLDH antigen only (4.0%) during the MIS. 

The ENAR approach used in this study detects 10-100x lower parasite densities than the 252

PfHRP2-based RDT itself 25 . Here, we confirm that a clear association exists between FN-RDT, isolates sequenced and also the number of NAAG and NDAG repeats varied between the 262 isolates. These results indicated high diversity of the P. malariae population on Bioko Island. 263

A slightly higher proportion, although not statistically significant, of non-falciparum 264 Plasmodium spp. parasites was found among FN-RDTs. P. malariae was found among 6.6% 265 of FN-RDTs compared to 3.8% among TP-RDTs. Similar, P. ovale spp. was more prevalent in 266 FN-RDTs (2.6%) than in TP-RDTs (0.9%). ΔCq values between pfhrp2 (x-axis) or pfhrp3 (y-axis) and pfrnr2e2. ΔCq thresholds (dashed 306 lines) were set at 1.0 for pfhrp2 and 2.9 for pfhrp3. For samples with a pfhrp3 deletion, the ΔCq 307 for pfhrp3 was set arbitrarily at 6.5. 308

The rate of FP-RDTs differed across age, level of anaemia, geographical location of residence, 310 and the socio-economic status (Supplementary figure 2) . Interestingly, no study participant with 311 a FP-RDT had a fever (>37.5° C) at the time of the survey, while 1.7% (13/763) of those with 312 TP-RDTs were recorded with fever. Eight factors from the MIS were used to identify risk 313 factors associated with FP-RDTs through multivariate logistic regression analysis in which the 314 outcome of the test was set as the outcome variable (Supplementary table 1 Malaria control programs rely on continuous and systematic collection of surveillance data for 364 decision making and resource allocation 34 . A critical measure that closely reflects malaria 365 transmission intensity is the parasite rate, the proportion of the population found to carry 366 parasites in their peripheral blood 35 . RDTs, more specifically PfHRP2-based RDTs, are the 367 most widely used test to measure parasite rates in endemic countries and are a cornerstone of 368 malaria control. However, here we have identified diagnostic performance issues, particularly 369 related to limited specificity. Therefore, malaria surveillance depending solely on RDTs needs 370 well integrated quality control procedures assessing the impact of reduced sensitivity and 371 specificity of the tests used in malaria control programs. In this report, we present an efficient 372 approach to assess the performance of field-deployed RDTs used for malaria surveillance on 373 large scale based on molecular analysis of NA retained on the RDTs. 374

In 4.7% (84/1800) of the negative RDTs we found Plasmodium spp. NA and identified these 375 as FN-RDT. The low proportion of FN-RDT can be explained by the low parasite densities of 376 these asymptomatic individuals (geometric mean of 5.4 Pf/µL) and the low amount of blood 377 (one drop corresponds to approximately 5 µL) used as starting material for the molecular 378

analysis. This is a limitation of our approach. Therefore, the true proportion of FN-RDTs in a 379 high prevalence setting such as Bioko Island is likely to be higher. 380

We identified Pf isolates with potential pfhrp3 deletions but not a single isolate with a 381 Our data support the notion that in malaria medium to high transmission settings, where 395 polyclonal Pf infections are common, only assays with the ability to identify masked pfhrp2 396 and/or pfhrp3 gene-deleted parasites should be used 38 . Importantly, to avoid false reporting of 397 pfhrp2 and/or pfhrp3 gene deletions, we used a robust and multi-layered approach by which 398 only samples with a pre-defined parasite density, successful amplification of the assays' internal 399 control, and additional, independent amplification of either pfmsp1 or pfmsp2, were included 400 into the analysis. 401

In our study, we discovered a significant proportion of FP-RDTs that were declared as malaria 402 positive in the field. Our findings are not unique to Bioko Island. In a study conducted in 403 

World malaria report 2020: 20 years of global progress and 467 challenges. Geneva: World Health Organization

The International Bank for Reconstruction 471 and Development / The World Bank

Scaling up diagnostic testing, 473 treatment and surveillance for malaria

Rapid diagnostic tests for malaria parasites

World Health Organization. Malaria rapid diagnostic test performance: results of WHO 479 product testing of malaria RDTs: round

Diagnostic Performance of Conventional and Ultrasensitive Rapid Diagnostic Tests for 482

Malaria in Febrile Outpatients in Tanzania

Malaria rapid diagnostic tests: challenges and prospects

Asymptomatic malaria infections: 486 detectability, transmissibility and public health relevance

False-negative 489 malaria rapid diagnostic test results and their impact on community-based malaria surveys in 490 sub-Saharan Africa

Global sequence 492 variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the 493 performance of malaria rapid diagnostic tests

A large 498 proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: 499 implications for malaria rapid diagnostic tests

Genetic diversity and deletion 501

Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum 502 malaria

HRP-2 deletion: a hole in the ship of malaria elimination

False-positive results for 506 rapid diagnostic tests for malaria in patients with rheumatoid factor

Plasmodium falciparum histidine-rich protein 2-based 509

immunocapture diagnostic assay for malaria: cross-reactivity with rheumatoid factors

Sensitive Detection of Plasmodium falciparum by Amplification of Multi-Copy Subtelomeric 536

Measurement of parasitological data by quantitative real-time PCR from controlled human 539 malaria infection trials at the Walter Reed Army Institute of Research

Multiplex qPCR 542 for Detection and Absolute Quantification of Malaria

A 544 multiplex qPCR approach for detection of pfhrp2 and pfhrp3 gene deletions in multiple strain 545 infections of Plasmodium falciparum

Biased 547 distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in 548

Transactions of The Royal Society of Tropical Medicine and Hygiene

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a 552 geographical bias

Heterogeneity in the circumsporozoite protein gene of 554

World Health Organization. Malaria surveillance, monitoring & evaluation: a reference 557 manual

Standardizing estimates of the Plasmodium 559 falciparum parasite rate

First 561 evidence of the deletion in the pfhrp2 and pfhrp3 genes in Plasmodium falciparum from

Human mobility 564 patterns and malaria importation on Bioko Island

Systematic 566 review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its 567 estimation and reporting in Plasmodium falciparum populations in Africa: review of published 568 studies 2010-2019

Proof of concept: 573 used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular 574 markers of anti-malarial resistance in

Molecular quantification of Plasmodium parasite density from the blood retained in used RDTs

Diagnostic 580 performance of an ultrasensitive HRP2-based malaria rapid diagnostic test kit used in surveys 581 of afebrile people living in Southern Ghana

Persistent Histidine-Rich Protein 2

Lactate Dehydrogenase, and Panmalarial Antigen Reactivity after Clearance of 584 <em>Plasmodium falciparum</em> Monoinfection

Characterization of Plasmodium Lactate Dehydrogenase and Histidine-Rich Protein

Clearance Patterns via Rapid On-Bead Detection from a Single Dried Blood Spot

Comparative field performance and adherence to test results of four malaria rapid diagnostic 591 tests among febrile patients more than five years of age in

Pf HRP2 and Pf LDH antigen 593 detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the 594 treatment of uncomplicated falciparum malaria

Overprescribing of antimalarials. Lancet Infectious Diseases -LANCET 596 INFECT DIS

Strengthening Surveillance Systems for Malaria Elimination by 598

Integrating Molecular and Genomic Data

testing in Africa: lessons learnt

Genetic diversity of Pf determined by size polymorphism of 605 pfmsp1 and pfmsp2. (b) Genetic diversity of P. malariae determined by the number of NAAG 606 and NDAG repeats in the pmcsp gene

Supplementary figure 2. FP-RDTs as a proportion of all positive RDTs stratified by age (a)

district (c) and socio-economic status (d)

The PfHRP2 antigen (97.4%) was much more often detected among FP-RDTs than the pLDH 410 antigen (11.2%). We were able to associate the false positivity of PfHRP2-RDTs with the recent 411 use of antimalarial drugs. It has been well established that antimalarial treatment leads to false 412 positive PfHRP2-RDT results because the PfHRP2 antigen persists in the blood days to weeks 413 after parasite clearance 22, [43] [44] [45] [46] . 414Remarkably, we found not only an association between the recent use of antimalarial drugs and 415 FP-RDTs, but also an indirect association with accessibility to antimalarial drugs. A higher 416 socio-economic status and living in the urban part of the Island directs towards increased 417 accessibility to antimalarial drugs. 418The impact of FP-RDTs differs greatly depending on the setting in which RDTs are deployed. 419In clinical settings, FP-RDTs might be less common, but the consequences are more serious 420 since unnecessary prescription of antimalarials might increase the risk of overlooking other, 421 life-threatening diseases causing fever or inducing side-effects caused by the antimalarial drugs 422 47 . However, if RDTs are used for epidemiological surveys, a high proportion of FP-RDTs due 423to PfHRP2 antigen persistence might lead to an overestimation of the malaria prevalence in 424 regions with good access to antimalarial treatment (urban regions) or in populations which are 425 more likely to receive antimalarial treatments (higher socio-economic status). One striking 426 example shown here is that the use of RDTs to assess the relationship between asymptomatic 427 malaria infection and anemia status in children < 5 years will lead to an underestimation of the 428 severe consequence of asymptomatic malaria infections on hemoglobin levels. 429The benefits and the challenges that come with large-scale deployment of molecular techniques 430 in malaria endemic regions have been discussed elsewhere 48 . And now, the COVID-19 431 pandemic has renewed the discussion regarding the importance of molecular testing as part of 432 public health systems across Africa 49 and will likely accelerate efforts to integrate molecular 433 tools for larger scale genomic surveillance of malaria into control programs. 434 24 Conclusion 435 Malaria surveillance programs based on RDT assessments of malaria prevalence should be 436 strengthened by the integration of molecular epidemiological data in the same setting. These 437 data will serve as an early warning system for (i) spread of Pf strains evading widely used 438 diagnostic tests, (ii) understanding overuse of malaria drugs, (iii) help with identifying fever 439 causing diseases beyond malaria, and (iv) help to clarify the burden of asymptomatic malaria 440 as a cause of severe to moderate anemia, particularly in children < 5 years. Group for their help with cultivating PfNF54, PfDD2 and PfHB3 parasites, whose DNA was 446 used as controls for the qHRP2/3-del assay. We would like to acknowledge Amanda Ross for 447 her support and guidance with the statistical analysis used in this manuscript. with FP-RDTs using community as a random effect. Crude and adjusted odds ratios and their 616 respective 95% confidence intervals were calculated based on comparison between FP-RDT 617 and TP-RDT. 618